Peter Loewen


About the Principal Investigator

E-mail: ploewen@interchange.ubc.ca
Phone: 604-374-4446

Training

Degree: B.Sc.(Pharm)
Institution: UBC
Year: 1993
Degree: ACPR
Organization: BC Children’s Hospital
Year: 1994
Degree: Pharm.D.
Organization: UBC
Year: 1996

Previous Positions

Position: Clinical Coordinator
Institution: Pharmaceutical Sciences Clinical Service Unit, UBC Hospital
Period: 2001 – 2006
Position: Clinical Assistant Professor of Pharmacy
Institution: UBC
Period: 1996-2004
Position: Coordinator
Institution: Advanced Pharmacotherapeutics, UBC Doctor of Pharmacy Program
Period: 1998-2004
Position: Clinical Associate Professor of Pharmacy
Institution: UBC
Period: 2004-2005

Current Positions

Position: Associate Professor of Pharmacy (Part Time)
Institution: UBC
Period: 2005 - present
Position: Regional Coordinator of Education & Research
Institution: Vancouver Coastal Health Authority/Providence Health Care Regional Pharmacy Services
Period: 2006 – present
Position: Coordinator
Institution: Pharmacy Practice Residency Program
Vancouver Coastal Health Authority/Providence Health Care Regional Pharmacy Services
Period: 2005 - present
Position: Pharmacotherapeutic Specialist
Institution: Medicine / Family Practice Pharmaceutical Sciences Clinical Service Unit, Vancouver General Hospital
Period: 1996 – present

Awards

Name: Preceptor of the Year Award
Organization: UBC Faculty of Pharmaceutical Sciences Doctor of Pharmacy Program. “In recognition of outstanding contributions to the teaching and professional development of the Pharm.D. students.”
Period: June 2007
Name: Preceptor of the Year Award
Organization: UBC Faculty of Pharmaceutical Sciences Doctor of Pharmacy Program. “In recognition of outstanding contributions to the teaching and professional development of the Pharm.D. students.”
Period: June 2007
Name: Preceptor of the Year Award
Organization: UBC Faculty of Pharmaceutical Sciences Doctor of Pharmacy Program. “In recognition of outstanding contributions to the teaching and professional development of the Pharm.D. students.”
Period: June 2005
Name: Fellow, Canadian Society of Hospital Pharmacists
Organization: Conferred January 2004 “in recognition of exemplary achievements and outstanding contributions to CSHP and the profession, demonstrating noteworthy service, practice excellence, leadership and commitment.”
Period: January 2004
Name: BC Branch Past-President’s Award
Organization: Canadian Society of Hospital Pharmacists
Period: 1999
Name: CSHP 2008/2009 National Patient Care Enhancement Award
Description: For “a project or program implemented in a hospital or healthcare system that promotes rational prescribing to enhance patient care or advances health care practitioners’ knowledge of drug therapy” for “Incidence, Severity and Preventability of Drug-Related Visits to the Emergency Department: A Prospective Study.”
Period: January 2009
Name: CSHP BC Branch Pharmacy Practice Residency Award
Description: “for a major project judged to be the most deserving in terms of representing a significant innovation, practical application and/or development in an institutional pharmacy practice setting” for “Implementation of a Quality Indicator for Inpatient Drug Therapy within a Large Urban Health Region”
Period: November 2007
Name: Canadian College of Clinical Pharmacy (CCCP) Original Research Award
Description: For “Implementation of a Personal Digital Assistant-based Drug-Problem Documentation Tool for  Pharmacy Practice in a Multi-site Healthcare Organization Setting”
Period: April 2005
Name: CSHP / BAXA Award
Description: For “Most positive impact on the future of hospital  pharmacy practice; a new idea or new application, or an idea that  has been used in another field but is new to  pharmacy” for “Implementation of a Personal Digital Assistant-based Drug-related Problem Documentation Tool for Pharmacy Practice in a Multi-site Healthcare  Organization Setting“
Period: 2005
Name: CSHP / Bristol Meyers Squibb Award
Description: for “An original scholarly paper or publication on the development of a clinical pharmacy program; Demonstrating significant innovations and developments in a clinical pharmacy program which may require further  development; or Original research which will contribute to the  improvement of a clinical pharmacy program” for “Implementation of a Personal Digital Assistant-based Drug-related Problem Documentation Tool for Pharmacy Practice in a Multi-site Healthcare  Organization Setting.”
Period: 2005
Name: Fellow, Canadian Society of Hospital Pharmacists
Description: Conferred January 2004 “in recognition of exemplary achievements and outstanding contributions to CSHP and the profession, demonstrating noteworthy service, practice excellence, leadership and commitment.”
Period: January 2004
Name: Canadian Society of Hospital Pharmacists Publication Award
Description: In recognition of an “outstanding contribution to the pharmacy literature”
Period: 1999
Name: Canadian Society of Hospital Pharmacists / Novartis Prize
Description: “for excellence in Pharmacoeconomics Research”
Period: 1998/99

Links

 

About the Research

Dr. Loewen’s research currently focuses on optimizing the use of evidence-based pharmacotherapeutic interventions in hospitalized patients, methods for measuring and improving the quality of drug therapy in general medical inpatients, and the influences of pharmacists beliefs on their practice behaviours.

Selected Projects in Progress

  • Bruchet N, de Lemos J, Loewen P. Using Quality Indicators to Measure the Quality of Care Provided by Clinical Pharmacists.
  • Slavik R, Parrott G, Loewen P.  Developing performance indicators for quality of pharmacotherapy in intensive care units.
  • Tejani A, Loewen P, Bachand R, Harder C, Young F, Kincade A.  Canadian pharmacists perceptions of the effects of drug promotion.
  • Loewen P, Lee KG, Lun E, Lo A. Implementing and evaluating a quality indicator for drug therapy in a multi-site health region: The Ideal Medication Intervention (IMI) Index.
  • Hohl, C, Abu-Laban R, Brubacher J, Loewen P, Sheps S, Hunte G, Anis A. Derivation of a Clinical Decision Rule to Identify Patients at Risk of Drug-Related Morbidity in the Emergency Department.
  • Cartwright A, deLemos J, Loewen P, Collins M.  Evaluation of the effectiveness of a program for hospital pharmacists to improve the management of chronic diseases reflected by the IMI index: closing the gap.
  • Tejani A, Loewen P, Jewesson P.  Cochrane Renal Group.  Probiotics for preventing urinary tract infections.

Selected Publications

  • Hohl C, Brubacher J, Zed P, Loewen P, Purssell R.  Do Emergency Physicians Attribute Drug-Related Emergency Department Visits to Medication-Related Problems?.  In press: Annals of Emergency Medicine
  • Mountford C, Loewen P, deLemos J, Lee T. Evaluation of quality and usability of common drug information databases.   In press: Can J Hosp Pharm.
  • Barry A, Loewen P, de Lemos J, Lee KG.  Reasons for non-use of proven pharmacologic interventions in hospitalised patients: Pharmacists’ perspectives.  Can J Hosp Pharm 2009;62(5):381–385.
  • Loewen P. Should the window for intravenous administration of tissue plasminogen activator in the treatment of acute ischemic stroke be extended to 4.5 hours? Can J Hosp Pharm 2009;62(3):248-51.
  • Zed PJ, Abu-Laban R, Balen RM, Loewen PS, Hohl CM, Brubacher JR, et al.  Incidence, Severity and Preventability of Drug-Related Visits to the Emergency Department: A Prospective Study. CMAJ 2008;178(12):1563-9.
  • Huang C, Loewen P, Pelletier T, Slater J, Chung M. Implementation of Proven Interventions in General Medical Inpatients: Development and evaluation of a new quality indicator for drug therapy. Qual Saf Health Care 2008;17:269-274.
  • Dahri K, Loewen P. The Risk of Bleeding with Warfarin: A systematic review and performance analysis of clinical prediction rules. Thrombosis & Haemostasis 2007;98:980-7.
  • McCormack J, Loewen P.  Adding “value” to clinical practice guidelines.  Can Fam Physician 2007;53:1326-1327.
  • Loewen P, Lamb S, Clugston P. A randomized, double-blind, trial of dolasetron versus droperidol for prophylaxis of postoperative nausea and vomiting in patients undergoing TRAM flap breast reconstruction surgery. Ann Plast Surg 2003;51:472-7.

« Back



a place of mind, The University of British Columbia

Faculty of Pharmaceutical Sciences
2146 East Mall
Vancouver, BC, Canada V6T 1Z3
Tel (Dean’s Office): 604.822.2343

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia